Latest Supply Chain News

Althea Group Holdings has sharply downgraded its FY25 financial guidance, citing significant challenges in its medicinal cannabis division and the strategic withdrawal from a vape product initiative. Despite the setback, the company highlights ongoing growth in its recreational cannabis operations and a strategic refocus on capital efficiency.

Bapcor Limited will announce its half-year financial results for the period ending December 2024 on 26 February, with a live briefing hosted by its top executives.

Ionic Rare Earths Limited has signed a non-binding MOU with South Korea's DNA Link to collaborate on rare earth magnet recycling and supply, marking a strategic push into Asia and the US markets.

GrainCorp Limited has announced an on-market buy-back of up to $50 million worth of its ordinary fully paid Class A shares, starting March 3, 2025. The move signals a strategic effort to enhance shareholder returns without specifying a fixed buy-back price or volume.

GrainCorp reported a solid FY24 with underlying EBITDA of $268 million and a net profit after tax of $77 million, underpinned by operational efficiency and strategic growth. The company announced a $50 million on-market share buy-back and reinforced its commitment to sustainability and shareholder returns.

GrainCorp projects a solid FY25 with EBITDA guidance up to $320 million and announces a $50 million share buy-back, underpinned by robust East Coast Australian grain production despite regional variances.

Magnum Mining & Exploration is recalibrating its supply chain strategy in response to new U.S. tariffs on steel and aluminium, engaging with Chinese partners and advancing its Buena Vista iron project.

Equinox Resources' Managing Director Zac Komur presented a detailed update on the Alturas Antimony Project, highlighting exceptional exploration results and strategic progress in British Columbia.

Treasury Wine Estates reports a robust first half of 2025, driven by luxury portfolio growth and DAOU integration, while premium segments face headwinds.

Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.

Insurance Australia Group (IAG) reported a robust half-year performance with a $778 million net profit, underpinned by premium growth and improved insurance margins. The company also raised its interim dividend by 20%, signaling confidence in its strategic execution.

Insurance Australia Group Limited (IAG) reported a 91.2% surge in net profit to $778 million for the half year ended December 2024, driven by robust insurance margins and higher investment income. The company also declared a 12-cent interim dividend, signaling confidence in its financial outlook.